The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP): (601292007-001)
Abstract
These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a quadrivalent human papillomavirus (HPV) vaccine licensed by the U.S. Food and Drug Administration on June 8, 2006. This report summarizes the epidemiology of HPV and associated diseases, describes the licensed HPV vaccine, and provides recommendations for its use for vaccination among females aged 9-26 years in the United States. Genital HPV is the most common sexually transmitted infection in the United States; an estimated 6.2 million persons are newly infected every year. Although the majority of infections cause no clinical symptoms and are self-limited, persistent infection with oncogenic types can cause cervical cancer in women. HPV infection also is the cause of genital warts and is associated with other anogenital cancers. Cervical cancer rates have decreased in the United States because of widespread use of Papanicolaou testing, which can detect precancerous lesions of the cervix before they develop into cancer; nevertheless, during 2007, an estimated 11,100 new cases will be diagnosed and approximately 3,700 women will die from cervical cancer. In certain countries where cervical cancer screening is not routine, cervical cancer is a common cancer in women. The licensed HPV vaccine is composed of the HPV L1 protein, the major capsid protein of HPV. Expression of the L1 protein in yeast using recombinant DNA technology produces noninfectious virus-like particles (VLP) that resemble HPV virions. The quadrivalent HPV vaccine is a mixture of four HPV type-specific VLPs prepared from the L1 proteins of HPV 6, 11, 16, and 18 combined with an aluminum adjuvant. Clinical trials indicate that the vaccine has high efficacy in preventing persistent HPV infection, cervical cancer precursor lesions, vaginal and vulvar cancer precursor lesions, and genital warts caused by HPV types 6, 11, 16, or 18 among females who have not already been infected with the respective HPV type. No evidence exists of protection against disease caused by HPV types with which females are infected at the time of vaccination. However, females infected with one or more vaccine HPV types before vaccination would be protected against disease caused by the other vaccine HPV types. The vaccine is administered by intramuscular injection, and the recommended schedule is a 3-dose series with the second and third doses administered 2 and 6 months after the first dose. The recommended age for vaccination of females is 11-12 years. Vaccine can be administered as young as age 9 years. Catch-up vaccination is recommended for females aged 13--26 years who have not been previously vaccinated. Vaccination is not a substitute for routine cervical cancer screening, and vaccinated females should have cervical cancer screening as recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Cancer Epidemiology and Prevention
(2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,369
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
Kreimer, A. R., Clifford, G. M., Boyle, P., & Franceschi, S. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0551 · Cited by 2,184
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. A. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,072
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
(1994) · PsycEXTRA Dataset · doi:10.1037/e546992006-001 · Cited by 1,714
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,602
Villa, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
NATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA
RICHART, R. M. (1967) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-196712000-00002 · Cited by 1,376
2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities
Wright, Jr. (2002) · JAMA · doi:10.1001/jama.287.16.2120 · Cited by 1,215
Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1111/j.1931-2393.2004.tb00002.x · Cited by 1,153
Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R., & Schiller, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12180 · Cited by 1,110
Epidemiology of Genital Human Papillomavirus Infection
Koutsky, P. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,107
Winer, R. L. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf180 · Cited by 1,044
American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer
Saslow, D., Runowicz, C. D., Solomon, D., Moscicki, A.-B., Smith, R. A., Eyre, H. J., & Cohen, C. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.6.342 · Cited by 927
Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia
Ho, G. Y. F., Burk, R. D., Klein, S., Kadish, A. S., Chang, C. J., Palan, P., Basu, J., Tachezy, R., Lewis, R., & Romney, S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.18.1365 · Cited by 803
Swan, J., Breen, N., Coates, R. J., Rimer, B. K., & Lee, N. C. (2003) · Cancer · doi:10.1002/cncr.11208 · Cited by 767
Smith, H. O., Tiffany, M. F., Qualls, C. R., & Key, C. R. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5826 · Cited by 736
Condom Use and the Risk of Genital Human Papillomavirus Infection in Young Women
Winer, R. L., Hughes, J. P., Feng, Q., O'Reilly, S., Kiviat, N. B., Holmes, K. K., & Koutsky, L. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053284 · Cited by 694
Sexual Behavior and Selected Health Measures: Men and Women 15-44 Years of Age, United States, 2002
Mosher, W. D., Chandra, A., & Jones, J. (2005) · PsycEXTRA Dataset · doi:10.1037/e609202007-001 · Cited by 693
The epidemiology of genital human papillomavirus infection
Trottier, H., & Franco, E. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.054 · Cited by 686
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682
Sexual Practices, Sexually Transmitted Diseases, and the Incidence of Anal Cancer
Daling, J. R., Weiss, N. S., Hislop, T. G., Maden, C., Coates, R. J., Sherman, K. J., Ashley, R. L., Beagrie, M., Ryan, J. A., & Corey, L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710153171601 · Cited by 665
Franco, E. L., Villa, L. L., Sobrinho, J. P., Prado, J. M., Rousseau, M., Désy, M., & Rohan, T. E. (1999) · The Journal of Infectious Diseases · doi:10.1086/315086 · Cited by 657
Johnson, L. G., Madeleine, M. M., Newcomer, L. M., Schwartz, S. M., & Daling, J. R. (2004) · Cancer · doi:10.1002/cncr.20364 · Cited by 641
Prevalence of HPV Infection among Men: A Systematic Review of the Literature
Dunne, E. F., Nielson, C. M., Stone, K. M., Markowitz, L. E., & Giuliano, A. R. (2006) · The Journal of Infectious Diseases · doi:10.1086/507432 · Cited by 615
Self-citationCastellsague, X., & Munoz, N. (2003) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003477 · Cited by 606
Immune responses to human papillomavirus
Stanley, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.002 · Cited by 586
Abma, J. C., Martinez, G. M., Mosher, W. D., & Dawson, B. S. (2004) · PsycEXTRA Dataset · doi:10.1037/e609162007-001 · Cited by 576
Carter, J. J., Koutsky, L. A., Hughes, J. P., Lee, S. K., Kuypers, J., Kiviat, N., & Galloway, D. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315498 · Cited by 575
Moscicki, A.-B., Shiboski, S., Broering, J., Powell, K., Clayton, L., Jay, N., Darragh, T. M., Brescia, R., Kanowitz, S., Miller, S. B., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70445-7 · Cited by 564
Moscicki, A.-B. (2001) · JAMA · doi:10.1001/jama.285.23.2995 · Cited by 557
Human Papillomavirus Infection in Women Infected with the Human Immunodeficiency Virus
Sun, X.-W., Kuhn, L., Ellerbrock, T. V., Chiasson, M. A., Bush, T. J., & Wright, T. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371903 · Cited by 543
Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
Goldie, S. J., Kohli, M., Grima, D., Weinstein, M. C., Wright, T. C., Bosch, F. X., & Franco, E. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh104 · Cited by 539
Model for Assessing Human Papillomavirus Vaccination Strategies
Elbasha, E. H., Dasbach, E. J., & Insinga, R. P. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1301.060438 · Cited by 491
Block, S. L., Nolan, T., Sattler, C., Barr, E., Giacoletti, K. E. D., Marchant, C. D., Castellsagué, X., Rusche, S. A., Lukac, S., Bryan, J. T., et al. (2006) · Pediatrics · doi:10.1542/peds.2006-0461 · Cited by 484
Myers, E. R., McCrory, D. C., Nanda, K., Bastian, L., & Matchar, D. B. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010166 · Cited by 470
Trends in the Incidence of Invasive and In Situ Vulvar Carcinoma
Judson, P. L., Habermann, E. B., Baxter, N. N., Durham, S. B., & Virnig, B. A. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000210268.57527.a1 · Cited by 469
Villa, L. L., Ault, K. A., Giuliano, A. R., Costa, R. L. R., Petta, C. A., Andrade, R. P., Brown, D. R., Ferenczy, A., Harper, D. M., Koutsky, L. A., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.068 · Cited by 469
Olsson, S.-E., Villa, L. L., Costa, R. L. R., Petta, C. A., Andrade, R. P., Malm, C., Iversen, O.-E., Høye, J., Steinwall, M., Riis-Johannessen, G., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.03.049 · Cited by 454
Mao, C., Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Wiley, D. J., Alvarez, F. B., Bautista, O. M., Jansen, K. U., & Barr, E. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000192397.41191.fb · Cited by 451
Miettinen, H., Lehto, S., Saikku, P., Haffner, S. M., Ronnemaa, T., Pyorala, K., & Laakso, M. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014934 · Cited by 447
The Estimated Direct Medical Cost of Sexually Transmitted Diseases Among American Youth, 2000
Chesson, H. W., Blandford, J. M., Gift, T. L., Tao, G., & Irwin, K. L. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3601104 · Cited by 444
Self-citationDevelopment and Duration of Human Papillomavirus Lesions, after Initial Infection
Winer, R. L., Kiviat, N. B., Hughes, J. P., Adam, D. E., Lee, S., Kuypers, J. M., & Koutsky, L. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/427557 · Cited by 417
Leyden, W. A., Manos, M. M., Geiger, A. M., Weinmann, S., Mouchawar, J., Bischoff, K., Yood, M. U., Gilbert, J., & Taplin, S. H. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji115 · Cited by 387
Evaluating Human Papillomavirus Vaccination Programs
Taira, A. V., Neukermans, C. P., & Sanders, G. D. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1011.040222 · Cited by 379
Duensing, S., & Münger, K. (2004) · International Journal of Cancer · doi:10.1002/ijc.11691 · Cited by 366
A Population-Based Study of Squamous Cell Vaginal Cancer: HPV and Cofactors
Daling, J. R., Madeleine, M. M., Schwartz, S. M., Shera, K. A., Carter, J. J., McKnight, B., Porter, P. L., Galloway, D. A., McDougall, J. K., & Tamimi, H. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2001.6502 · Cited by 346
van Seters, M., van Beurden, M., & de Craen, A. J. M. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.02.012 · Cited by 338
Schlecht, N. F. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg037 · Cited by 338
Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs
Kulasingam, S. L. (2003) · JAMA · doi:10.1001/jama.290.6.781 · Cited by 337
Carter, J. J., Koutsky, L. A., Wipf, G. C., Christensen, N. D., Lee, S.-K., Kuypers, J., Kiviat, N., & Galloway, D. A. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.927 · Cited by 326
Ley, C., Bauer, H. M., Reingold, A., Schiffman, M. H., Chambers, J. C., Tashiro, C. J., & Manos, M. M. (1991) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/83.14.997 · Cited by 320
Molano, M. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg171 · Cited by 315
Cost Effectiveness of a Potential Vaccine for Human papillomavirus
Sanders, G. D., & Taira, A. V. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0901.020168 · Cited by 310
Barnabas, R. V., Laukkanen, P., Koskela, P., Kontula, O., Lehtinen, M., & Garnett, G. P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030138 · Cited by 293
Opalka, D., Lachman, C. E., MacMullen, S. A., Jansen, K. U., Smith, J. F., Chirmule, N., & Esser, M. T. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.1.108-115.2003 · Cited by 276
Vulvar Intraepithelial Neoplasia: Aspects of the Natural History and Outcome in 405 Women
Jones, R. W., Rowan, D. M., & Stewart, A. W. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000187301.76283.7f · Cited by 273
Greer, C. E., Wheeler, C. M., Ladner, M. B., Beutner, K., Coyne, M. Y., Liang, H., Langenberg, A., Yen, T. S., & Ralston, R. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.8.2058-2063.1995 · Cited by 269
Anal Cancer Incidence: Genital Warts, Anal Fissure or Fistula, Hemorrhoids, and Smoking
Holly, E. A., Whittemore, A. S., Aston, D. A., Ahn, D. K., Nickoloff, B. J., & Kristiansen, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.22.1726 · Cited by 262
Evaluation of Genital Sites and Sampling Techniques for Detection of Human Papillomavirus DNA in Men
Weaver, B. A., Feng, Q., Holmes, K. K., Kiviat, N., Lee, S., Meyer, C., Stern, M., & Koutsky, L. A. (2004) · The Journal of Infectious Diseases · doi:10.1086/381395 · Cited by 253
Determinants of Genital Human Papillomavirus Detection in a US Population
Peyton, C. L., Gravitt, P. E., Hunt, W. C., Hundley, R. S., Zhao, M., Apple, R. J., & Wheeler, C. M. (2001) · The Journal of Infectious Diseases · doi:10.1086/320696 · Cited by 252
Dias, D., Van Doren, J., Schlottmann, S., Kelly, S., Puchalski, D., Ruiz, W., Boerckel, P., Kessler, J., Antonello, J. M., Green, T., et al. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.8.959-969.2005 · Cited by 241
BURK, R. D., KELLY, P., FELDMAN, J., BROMBERG, J., VERMUND, S. H., DEHOVITZ, J. A., & LANDESMAN, S. H. (1996) · Sexually Transmitted Diseases · doi:10.1097/00007435-199607000-00013 · Cited by 227
Seroprevalence of Human Papillomavirus Type 16 Infection in the United States
Stone, K. M., Karem, K. L., Sternberg, M. R., McQuillan, G. M., Poon, A. D., Unger, E. R., & Reeves, W. C. (2002) · The Journal of Infectious Diseases · doi:10.1086/344354 · Cited by 222
Self-citationNational Registry for Juvenile-Onset Recurrent Respiratory Papillomatosis
Reeves, W. C., Ruparelia, S. S., Swanson, K. I., Derkay, C. S., Marcus, A., & Unger, E. R. (2003) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archotol.129.9.976 · Cited by 218
Self-citationInsinga, R. P., Dasbach, E. J., & Myers, E. R. (2003) · Clinical Infectious Diseases · doi:10.1086/375074 · Cited by 216
Insinga, R. P., Dasbach, E. J., & Elbasha, E. H. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523110-00004 · Cited by 195
Natural History of Human Papillomavirus Type 16 Virus-Like Particle Antibodies in Young Women
Ho, G. Y. F., Studentsov, Y. Y., Bierman, R., & Burk, R. D. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-03-0191 · Cited by 195
Genital Human Papillomavirus Infection in Men
Porche, D. J. (2007) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2007.08.026 · Cited by 194
Cancer Incidence in Kentucky, Pennsylvania, and West Virginia: Disparities in Appalachia
Lengerich, E. J., Tucker, T. C., Powell, R. K., Colsher, P., Lehman, E., Ward, A. J., Siedlecki, J. C., & Wyatt, S. W. (2005) · The Journal of Rural Health · doi:10.1111/j.1748-0361.2005.tb00060.x · Cited by 175
Low risk of perinatal transmission of human papillomavirus: Results from a prospective cohort study
Heather Watts, D., Koutsky, L. A., Holmes, K. K., Goldman, D., Kuypers, J., Kiviat, N. B., & Galloway, D. A. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)80027-6 · Cited by 158
Manhart, L. E., Holmes, K. K., Koutsky, L. A., Wood, T., Kenney, D. L., Feng, Q., & Kiviat, N. B. (2006) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000204545.89516.0a · Cited by 156
The health care costs of cervical human papillomavirus–related disease
Insinga, R. P., Glass, A. G., & Rush, B. B. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.01.042 · Cited by 145
Human Papillomavirus Genotypes and the Cumulative 2‐Year Risk of Cervical Precancer
Wheeler, C. M., Hunt, W. C., SCHIFFMAN, M. H., Castle, P. E., & Atypical Squamous Cells of Undetermined Significance/Low‐Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group (2006) · The Journal of Infectious Diseases · doi:10.1086/507909 · Cited by 145
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Cervical Cancer Incidence in a Prevaccine Era in the United States, 1998–2002
Saraiya, M., Ahmed, F., Krishnan, S., Richards, T. B., Unger, E. R., & Lawson, H. W. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000254165.92653.e8 · Cited by 140
Self-citationHuman Papillomavirus Infection in Men Attending a Sexually Transmitted Disease Clinic
Baldwin, S. B., Wallace, D. R., Papenfuss, M. R., Abrahamsen, M. E., Vaught, L., Kornegay, J. R., Hallum, J. A., Redmond, S. A., & Giuliano, A. R. (2003) · The Journal of Infectious Diseases · doi:10.1086/368220 · Cited by 133
Lifetime Number of Partners As the Only Independent Risk Factor for Human Papillomavirus Infection
KARLSSON, R., Jönsson, M., Edlund, K., Evander, M., GUSTAVSSON, Å., BODÉN, E., Rylander, E., & Wadell, G. (1995) · Sexually Transmitted Diseases · doi:10.1097/00007435-199503000-00008 · Cited by 118
Increased Incidence of Cancer among Homosexual Men, New York City and San Francisco, 1978-1990
Koblin, B. A., Hessol, N. A., Zauber, A. G., Taylor, P. E., Buchbinder, S., Katz, M. H., & Stevens, C. E. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008861 · Cited by 102
Genital human papillomavirus infection in women who have sex with women: A review
Marrazzo, J. M., Stine, K., & Koutsky, L. A. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106681 · Cited by 99
Hernandez, B. Y., McDuffie, K., Goodman, M. T., Wilkens, L. R., Thompson, P. J., Zhu, X., Wong, W., & Ning, L. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.513-517.2006 · Cited by 63
Pagliusi, S. R., Dillner, J., Pawlita, M., Quint, W. G. V., Wheeler, C. M., & Ferguson, M. A. J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.016 · Cited by 44
Zelmanowicz, A. D. M., SCHIFFMAN, M. H., Herrero, R., Goldstein, A. M., Sherman, M. E., Burk, R. D., Gravitt, P. E., Viscidi, R. P., Schwartz, P. E., Barnes, W. A., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21048 · Cited by 39
Hand-genital transmission of genital warts? An analysis of prevalence data
Fairley, C. K., Gay, N., Forbes, A. B., Abramson, M. J., & Garland, S. M. (1995) · Epidemiology and Infection · doi:10.1017/s0950268800058234 · Cited by 39
Etiology and Prevention of Cervical Adenocarcinomas
Hildesheim, A., & de González, A. B. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj098 · Cited by 25
Management of Women With Cervical Cytology Interpreted as ASC-US or as ASC-H
Cox, J. T. (2005) · Clinical Obstetrics & Gynecology · doi:10.1097/01.grf.0000151571.91814.f3 · Cited by 24
Cited by
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21820 · Cited by 9,533
Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H., & Jemal, A. (2025) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21871 · Cited by 3,060
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A., & Berman, S. M. (2007) · Clinical Infectious Diseases · doi:10.1086/511430 · Cited by 1,973
Metadata
- Authors
- Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R.
- Venue
- PsycEXTRA Dataset
- Published
- 2007
- Volume
- 56
- Issue
- RR-2
- Pages
- 1-24
- OpenAlex
- W2892002136
- Cited by
- 1,882
- References
- 89
- Type
- dataset
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.